These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5929188)

  • 1. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
    Oehme P; Schwarz K
    Dtsch Gesundheitsw; 1966 Apr; 21(17):792-8. PubMed ID: 5929188
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's syndrome--modern therapy, known facts and unanswered questions.
    Albert E
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep; 6(5):229-46. PubMed ID: 4604872
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parkinson's syndrome. 1. Biochemistry of the monoamines].
    Roos BE
    Lakartidningen; 1970 Oct; 67(42):4803-6. PubMed ID: 5483442
    [No Abstract]   [Full Text] [Related]  

  • 4. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug-induced Parkinson's syndrome].
    Degkwitz R
    Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
    Greer M; Anton AH
    Trans Am Neurol Assoc; 1970; 95():247-8. PubMed ID: 4328099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].
    Buscaino GA; Sori A; Campanella G
    Rev Neurol (Paris); 1972 Aug; 127(2):301-2. PubMed ID: 4666634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
    Hornykiewicz OD
    Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
    Morselli PL; Rizzo M; Tognoni G
    Recenti Prog Med; 1970 Feb; 48(2):97-124. PubMed ID: 5467589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dopa metabolism in relation to the therapy of Parkinson's syndrome].
    Pletscher A; Bartholini G
    Actual Pharmacol (Paris); 1971; 24():27-49. PubMed ID: 5150621
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
    Brockmann AW
    Ther Ggw; 1970 Nov; 109(11):1590-3. PubMed ID: 5486128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apomorphine in the biochemical concept of Parkinson's tremor].
    Brinkmann R; Strian F
    Nervenarzt; 1974 Sep; 45(9):474-6. PubMed ID: 4437688
    [No Abstract]   [Full Text] [Related]  

  • 14. L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.
    Davidson L; Lloyd K; Dankova J; Hornykiewicz O
    Experientia; 1971 Sep; 27(9):1048-9. PubMed ID: 5116129
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacology of parkinsonism (a review).
    Klawans HL
    Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease].
    Ferrari M; Furlanut M; Battistin L; Benedetti A; Mingrino S
    Clin Ter; 1971 May; 57(4):351-6. PubMed ID: 5110949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hereditary aspects of Parkinson's disease (review of the literature)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(6):919-26. PubMed ID: 4584983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C
    Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
    [No Abstract]   [Full Text] [Related]  

  • 19. Basic concepts underlying recent developments in the field of Parkinson's disease.
    Carlsson A
    Contemp Neurol Ser; 1971; 8():1-31. PubMed ID: 4352437
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent advances in the therapy of Parkinson's syndrome].
    Lombardo L
    Gac Med Mex; 1974 Jun; 107(6):513-24. PubMed ID: 4448355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.